Skip to content

InsiderTradesSIGMA

RecommendationsTOP Fundamental picks TerminalNEW

Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FR US DE CH GB CA IT ES NL BE NO FI DK AU AT IE KR IN JP HK+ 8 markets

Recommendations
Fundamental picks
Terminal
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Archive

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

Built bySimon Azoulay

All systems operational

Companies · Healthcare & Pharma · InsiderTrades Sigma · page 34

Sector3,940

Healthcare & Pharma

Modus Therapeutics Holding AB (publ)

Modus Therapeutics Holding AB (publ)

Mohini Health & Hygiene Limited

Molecular Partners AG

Molecular Partners Ltd

Molecular Templates, Inc.

Moleculin Biotech, Inc.

Molina Healthcare, INC.

Monopar Therapeutics

Monte Rosa Therapeutics, Inc.

MoonLake Immunotherapeutics

Morepen Laboratories Limited

Morphic Holding, Inc.

Motion Acquisition Corp.

Motus GI Holdings, Inc.

Mountain Crest Acquisition Corp. III

MusclePharm Corp

Mustang Bio, INC.

MyMD Pharmaceuticals, Inc.

Myovant Sciences Ltd.

Myriad Genetics INC

NASDAQ STOCKHOLM AKTIEBOLAG

NATURAL ALTERNATIVES INTERNATIONAL INC

NEKTAR THERAPEUTICS

NETCARE LIMITED

NEUROONE MEDICAL TECHNOLOGIES Corp

NFL Biosciences

NGL Fine-Chem Limited

NGM Biopharmaceuticals INC

NOLATO AKTIEBOLAG

NOVATION COMPANIES, INC.

NRX Pharmaceuticals, Inc.

NU Skin Enterprises, INC.

Nabriva Therapeutics plc

Namn: Vimian Group AB (publ)

← PreviousPage 34 of 79Next →